Disturbing CUL4B expression could increase sensitivity to chemotherapy in lymphoblastoid cells, non-small-cell lung cancer cells, osteosarcoma and bladder cancer cells (29, 39, 40). This evidence concerns the gene CUL4B and urinary bladder carcinoma.